Prevalence, predictors, and prognostic implications of improvement in left ventricular systolic function and clinical status in patients >70 years of age with recently diagnosed systolic heart failure

American Journal of Cardiology

Volumn 92, Issue 2, 2003, Pages 166-172

  Cioffi, Giovanni ^a   Stefenelli, Carlo ^b   Tarantini, Luigi ^b   Opasich, Cristina ^b  

^a Villa Bianca Hospital   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; SPIRONOLACTONE;

AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH STATUS; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SYSTOLE; TREATMENT OUTCOME;

EID: 0037969041     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00532-0     Document Type: Article

References (30)

1. How to diagnose diastolic heart failure. Eur Heart J. 19:1998;990-1003.
2. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimentional ecocardiography. J Am Soc Echocardiography. 2:1989;358.
3. Miyatake K., Izumi S., Okamoto M., Kinoshita N., Asonuma H., Nakagawa H., Yamamoto K., Takamiya M., Sakakibara H., Nimura Y. Semiquantitative grading of severity of mitral regurgitation by real time two dimensional Doppler flow imaging technique. J Am Coll Cardiol. 7:1986;82-88.
4. Pozzoli M., Capomolla S., Pinna G., Cobelli F., Tavazzi L. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. Am J Cardiol. 27:1996;883-893.
5. Temporelli P.L., Scapellato F., Corra U., Eleuteri E., Imparato A., Giannuzzi P. Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am J Cardiol. 83:1999;724-727.
6. Gola A., Pozzoli M., Capomolla S., Traversi E., Sanarico M., Cobelli F., Tavazzi L. Comparison of Doppler echocardiography with thermodilution for assessing cardiac output in advanced congestive heart failure. Am J Cardiol. 6:1996;708-712.
7. Capomolla S., Febo O., Caporotondi A., Guazzotti G., Gnemmi M., Rossi A., Pinna G., Maestri R., Cobelli F. Non-invasive estimation of right atrial pressure by combined Doppler echocardiographic measurements of the inferior vena cava in patients with congestive heart failure. Ital Heart J. 1:2000;684-690.
8. Steimle A.E., Stevenson L.W., Fonarow G.C., Hamilton M.A., Moriguchi J.D. Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol. 23:1994;553-559.
9. Cicoira M., Zanolla L., Latina L., Rossi A., Golia G., Brighetti G., Zardini P. Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with "classical" diagnosis of idiopathic dilated cardiomyopathy. Eur Heart Fail J. 3:2001;323-330.
10. O'Keefe J.H. Jr, Magalshi A., Stevens T.L., Bresnahan D.R. Jr, Alaswad K., Krueger S.K., Bateman T.M. Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure. J Nucl Cardiol. 7:2000;3-7.
11. Opasich C., Rapezzi C., Lucci D., Gorini M., Pozzar F., Zanelli E., Tavazzi L., Maggioni A.P. Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF registry). Am J Cardiol. 88:2001;382-387.
12. Cioffi G., Stefenelli C. Tolerability and clinical effects of carvedilol in very elderly patients with heart failure due to left ventricular dysfunction. Ital Heart J. 2:(suppl 12):2001;1319-1329.
13. Lowes B.D., Gill E.A., Abraham W.T., Larrain J.R., Robertson A.D., Bristow M.R., Gilbert E.M. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol. 83:1999;1201-1205.
14. Capomolla S., Febo O., Gnemmi M., Riccardi G., Opasich C., Caporotondi A., Mortara A., Pina G.D., Cobelli F. Beta-blockade therapy in chronic heart failure diastolic function and mitral regurgitation improvement by carvedilol . Am Heart J. 139:2000;596-608.
15. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
16. Bristow M.R., Gilbert E.M., Abraham W.T., Adams K.F., Fowler M.B., Hershberger R.E., Kubo S.H., Narahara K.A., Ingersoll H., Krueger S., Young S., Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation. 94:1996;2807-2816.
17. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II) a randomized trial . Lancet. 353:1999;9-13.
18. Metra M., Nardi M., Giubbini R., Cas L.D. Effect of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2:1994;1678-1687.
19. Eichhorn E.J., Heesch C.M., Risser R.C., Marcoux L.G., Hatfield B.A. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol. 25:1995;154-162.
20. Bristow M.R., O'Connell J.B., Gilbert E.M., French W.J., Leatherman G., Kantrowitz N.E., Orie J., Smucker M.L., Marshall G., Kelly P. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation. 89:1994;1632-1642.
21. Woodley S.L., Gilbert E.M., Anderson J.L., O'Connell J.B., Deitchman D., Yanowitz F.G., Mealey P.C., Volkman K., Renlund D.G., Menlove R., Bristow M.R. B-blockade with bucindolol in heart failure due to ischemic vs idiopathic dilated cardiomyopathy. Circulation. 84:1991;2426.:2441.
22. Packer M., Colucci W.S., Sackner-Bernstein J.D., Liang C., Goldscher D.A., Freeman I., Kukin M.L., Kinhal V., Udelson J.E., Klapholz M., et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial. Circulation. 94:1996;2793-2799.
23. Olsen S.L., Gilbert E.M., Renlund D.G., Mealey P.C., Taylor D.O., Yanowitz F.D., Bristow M.R. Carvedilol improves left ventricular function and symptoms in heart failure a double blind randomized study . J Am Coll Cardiol. 25:1995;1225-1231.
24. Krum H., Sackner-Bernstein J.D., Goldsmith R.L., Kukin M.L., Schwartz B., Penn J., Medina N., Yushak M., Horn E., Katz S.D., Levin H.R., et al. Double-blind placebo-controlled study of long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation. 92:1995;1499-1506.
25. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratas G, Jessup ML, et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult. A report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Available at: http://www.acc.org/clinical/guidelines/failure/hf_index.htm. 2001.
26. Shindler D.M., Kostis J.B., Yusuf S., Quinones M.A., Pitt B., Stewart D., Pinkett T., Ghali J.K., Wilson A.C. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 77:1996;1017-1020.
27. Solang L., Malmberg K., Ryden L. Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J. 20:1999;789-795.
28. Lavine S.J., Gellman S.D. Treatment of heart failure in patients with diabetes mellitus. Drugs. 62:2002;285-307.
29. Swan J.W., Anker S.D., Walton C., Godsland I.F., Clark A.L., Leyva F., Stevenson J.C., Coats A.J. Insulin resistance in chronic heart failure relation to severity and etiology of heart failure . J Am Coll Cardiol. 30:1997;527-532.
30. Watanabe K., Sekiya M., Tsuruoka T., Funada J., Kameoka H., Miyagawa M., Kohara K. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. J Hypertens. 17:1999;1161-1168.